| Sentire Medical Systems, Inc | US | unknown | $1.2M |
| Serif Biomedicines | US | seed | $50.0M |
| Sidera Bio | DK | series-a | $100.4M |
| Sidewinder Therapeutics | US | series-b+ | $200.0M |
| Sidewinder Therapeutics | US | series-b+ | $200.0M |
| Sidewinder Therapeutics | US | series-b+ | $162.0M |
| SINTX TECHNOLOGIES, INC. | US | unknown | $2.0M |
| Sirius Therapeutics | US | series-b+ | $100.0M |
| SIRPANT IMMUNOTHERAPEUTICS INC | US | unknown | $2.0M |
| SNIPR Biome | DK | series-b+ | $108.0M |
| SNIPR Biome | DK | series-b+ | $37.8M |
| Solve Therapeutics | US | series-a | $120.0M |
| Solve Therapeutics | US | series-b+ | $321.0M |
| Somite AI | US | pre-seed | $10.0M |
| SPATIAL GENOMICS, INC. | US | unknown | $2.7M |
| SPECTREE INC. | US | unknown | $1.9M |
| SPIKEGADGETS, INC. | US | unknown | $2.8M |
| Splice Bio | ES | series-b+ | $215.0M |
| SpliceBio | ES | series-b+ | $135.0M |
| Spore.Bio | FR | series-a | $37.8M |
| Spore.Bio | FR | series-a | $31.3M |
| STEP Pharma | FR | unknown | $2.7M |
| Stipple Bio | US | series-a | $109.0M |
| Stipple Bio | US | series-a | $100.0M |
| Strand Therapeutics | US | series-b+ | $153.0M |
| STRYKAGEN CORPORATION | US | unknown | $2.0M |
| Superluminal Medicines, Inc. | US | unknown | $5.0M |
| SUS CLINICALS INC | US | unknown | $2.0M |
| Switch Bioworks | US | seed | $25.0M |
| SwitchPoint Bio Holding, Inc. | US | unknown | $5.3M |
| Syremis Therapeutics | US | series-a | $165.0M |
| T-CURX | DE | series-a | $18.4M |
| T-CURX | DE | series-a | $23.8M |
| T-Therapeutics | GB | series-a | $29.7M |
| T3D Therapeutics, Inc. | US | unknown | $2.5M |
| Tamarind Bio | US | seed | $1.0M |
| Tamarind Bio, Inc. | US | unknown | $13.6M |
| TargED | NL | series-a | $37.8M |
| Tempero Bio, Inc. | US | unknown | $77.0M |
| Tenvie Therapeutics | US | series-a | $200.0M |
| Terremoto Biosciences | US | series-b+ | $250.0M |
| Terremoto Biosciences, Inc. | US | unknown | $40.7M |
| Terrestrial Bio, Inc. | US | unknown | $57.3M |
| TETRAIMAGING LLC | US | unknown | $2.0M |
| Tetrous, Inc. | US | unknown | $1.7M |
| The Synthesis Company | US | seed | $1.0M |
| THYREOS INC | US | unknown | $1.4M |
| TIBA BIOTECH LLC | US | unknown | $2.9M |
| TIBARAY, INC. | US | unknown | $2.0M |
| Tinos Therapeutics, Inc. | US | unknown | $2.2M |
| Tolemy Bio | GB | pre-seed | $1.5M |
| Topo Therapeutics, Inc. | US | unknown | $10.6M |
| Torrey Pines Logic, Inc. | US | unknown | $1.9M |
| Tortugas Neuroscience | US | series-a | $106.0M |
| TRACE-ABILITY INC | US | unknown | $3.0M |
| Triana Biomedicines | US | series-b+ | $230.0M |
| TRIDENT SENSING, INC. | US | unknown | $1.9M |
| Trimtech Therapeutics | GB | seed | $31.0M |
| Trimtech Therapeutics | GB | seed | $31.0M |
| Trogenix | GB | series-a | $102.6M |
| TURNER SCIENTIFIC LLC | US | unknown | $1.7M |
| UNANDUP, LLC | US | unknown | $3.3M |
| UniteLabs | DE | pre-seed | $3.3M |
| UROGENIE LLC | US | unknown | $2.6M |
| Valinor | US | seed | $13.0M |
| VERACHEM LLC | US | unknown | $1.8M |
| Veradermics | US | series-b+ | $261.2M |
| Verdiva Bio | GB | series-a | $411.0M |
| Verdiva Bio | GB | series-a | $411.0M |
| Verdiva Bio (alt) | GB | series-a | $411.0M |
| Vergent Bioscience, Inc. | US | unknown | $18.7M |
| Verne Robotics | US | seed | $1.0M |
| Verrica Pharmaceuticals Inc. | US | unknown | $50.0M |
| Viocare, Inc. | US | unknown | $2.0M |
| VIVOVERSE, LLC | US | unknown | $1.8M |
| VOXIMETRY INC | US | unknown | $4.0M |
| VST BIO Corp | US | unknown | $31.9M |
| VULINTUS, INC | US | unknown | $1.9M |
| Wild Bioscience | GB | series-a | $70.0M |
| Wild Bioscience | GB | series-a | $64.8M |
| Windward Bio | CH | series-b+ | $165.0M |
| X-Therma Inc. | US | unknown | $2.0M |
| Xaira Therapeutics | US | series-a | $1.0B |
| Xampla | GB | series-a | $11.9M |
| Xanadu Bio, Inc. | US | unknown | $11.0M |
| XUV LASERS, INC. | US | unknown | $3.0M |
| Zephyr AI | US | series-a | $111.0M |
| Zeteo Tech, Inc. | US | unknown | $1.9M |